Zimmer Biomet Holdings, INC Form 4 insider transactions

Director Maria Teresa Hilado reports acquiring phantom stock units in Zimmer Biomet Holdings, Inc. through a deferred compensation plan.

Director Syed A. Jafry reports acquiring phantom stock units in Zimmer Biomet Holdings, Inc. through a deferred compensation plan.

Director Arthur J. Higgins reports acquiring phantom stock units in Zimmer Biomet Holdings, Inc. through a deferred compensation plan.

Director Michael J. Farrell reports acquisition of phantom stock units in Zimmer Biomet Holdings, Inc. under the deferred compensation plan.

Director Kolli Sreelakshmi reports acquiring phantom stock units in Zimmer Biomet Holdings, Inc. through a deferred compensation plan.

Director Christopher B. Begley reports acquiring phantom stock units in Zimmer Biomet Holdings, Inc. through a deferred compensation plan.

Director Robert Hagemann reports acquisition of phantom stock units in Zimmer Biomet Holdings, Inc. under deferred compensation plan.

Director Louis Shapiro reports acquiring phantom stock units in Zimmer Biomet Holdings, Inc. under the Deferred Compensation Plan for Non-Employee Directors.

Lori Winkler, SVP and CHRO of Zimmer Biomet Holdings, Inc., reported the vesting of restricted stock units and subsequent stock transactions on March 6, 2024.

Wilfred van Zuilen, Group President, EMEA at Zimmer Biomet Holdings, Inc., reports transactions involving common stock and restricted stock units.

Zimmer Biomet's CFO, Suketu Upadhyay, reported the vesting of restricted stock units and subsequent transactions involving common stock.

Ivan Tornos, President & CEO of Zimmer Biomet Holdings, Inc., reports the vesting of restricted stock units and subsequent stock sales to cover tax obligations.

Paul Stellato, VP, Controller & CAO of Zimmer Biomet Holdings, Inc., reports the vesting of restricted stock units and related stock transactions.

Chad F. Phipps, Sr. VP/Gen Counsel/Secretary of Zimmer Biomet Holdings, Inc., reports the vesting of restricted stock units and subsequent tax withholding.

Rachel Ellingson, SVP & Chief Strategy Officer of Zimmer Biomet, reports the vesting of restricted stock units and subsequent transactions involving common stock.

Mark Bezjak, President, Americas at Zimmer Biomet Holdings, Inc., reported the vesting of restricted stock units and subsequent stock transactions on March 6, 2024.

Sang Yi, Group President, Asia Pacific at Zimmer Biomet Holdings, Inc., reports the vesting of restricted stock units and the sale of shares.

Chad F. Phipps, Sr. VP/Gen Counsel/Secretary of Zimmer Biomet Holdings, Inc., reports the acquisition and disposal of common stock and restricted stock units on March 1, 2024.

Sang Yi, Group President, Asia Pacific at Zimmer Biomet Holdings, Inc., reported the acquisition and disposal of common stock and restricted stock units on March 1, 2024.

Lori Winkler, SVP and CHRO of Zimmer Biomet, reports the vesting of restricted stock units and subsequent tax withholding.

Executive VP and CFO of Zimmer Biomet, Suketu Upadhyay, reports the vesting and disposal of restricted stock units and shares acquired through the employee stock purchase plan.

Zimmer Biomet's President and CEO, Ivan Tornos, reports the vesting of restricted stock units and related stock transactions.

Chad F. Phipps, a Senior VP/General Counsel/Secretary at Zimmer Biomet Holdings, Inc., reported the vesting of restricted stock units and subsequent tax withholding.

Rachel Ellingson, SVP & Chief Strategy Officer of Zimmer Biomet Holdings, Inc., reports the acquisition and disposal of common stock and restricted stock units.

Lori Winkler, SVP and CHRO of Zimmer Biomet, reports the vesting of restricted stock units and subsequent sale of shares to cover tax obligations.

Mark Bezjak, President of Americas at Zimmer Biomet Holdings, reports the vesting and subsequent sale of restricted stock units to cover tax obligations.

Group President, Asia Pacific, Sang Yi, reports the vesting of restricted stock units and subsequent disposal of shares.